Researchers at University of California San Diego School of Medicine and Mayo Clinic provide the first evidence that the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors (GIST), which ...
Nov 1, 2016
0
2
Researchers at UC San Diego School of Medicine conducted the first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The ...
May 1, 2015
0
84
The doctor says: "We offer two kinds of surgery for your cancer. Both procedures have 80 percent cure rates. After the first kind, 4 percent of patients have serious complications. In the second type, 20 percent simply die. ...
Mar 26, 2015
0
8
Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach ...
Oct 7, 2014
0
0
Gastrointestinal stromal tumours (GIST) are relatively rare tumours of the gastrointestinal tract that can occur both as a harmless incidental finding and as aggressive, malignant disease. Two key genetic mutations that can ...
Sep 11, 2013
0
0
New research by neuroscientists at UC Berkeley, suggests that the human brain is not detail-oriented, but opts for the big picture when it comes to hearing.
Jun 13, 2013
1
0
Interim results of an EORTC intergroup trial have confirmed that adjuvant imatinib impacts short-term freedom from relapse in patients with localized, surgically resected, high/ intermediate-risk GIST. In the high-risk subgroup, ...
May 29, 2013
0
0
(Medical Xpress)—Some children who have trouble learning in the classroom have difficulty switching their listening attention and so have trouble following a conversation from one talker to the next, according to a University ...
Apr 5, 2013
0
0
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report ...
Nov 21, 2012
0
0
(HealthDay) -- Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors (GIST) who have failed to respond to imatinib and sunitinib, according ...
May 23, 2012
0
0
